Global Antivirals Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Antivirals market size was valued at US$ 43650 million in 2023. With growing demand in downstream market, the Antivirals is forecast to a readjusted size of US$ 60070 million by 2030 with a CAGR of 4.7% during review period.
The research report highlights the growth potential of the global Antivirals market. Antivirals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Antivirals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Antivirals market.
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Antivirals market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Antivirals market. It may include historical data, market segmentation by Type (e.g., Generic, Branded), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Antivirals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Antivirals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Antivirals industry. This include advancements in Antivirals technology, Antivirals new entrants, Antivirals new investment, and other innovations that are shaping the future of Antivirals.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Antivirals market. It includes factors influencing customer ' purchasing decisions, preferences for Antivirals product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Antivirals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Antivirals market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Antivirals market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Antivirals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Antivirals market.
Market Segmentation:
Antivirals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Antivirals market?
What factors are driving Antivirals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antivirals market opportunities vary by end market size?
How does Antivirals break out type, application?
According to our LPI (LP Information) latest study, the global Antivirals market size was valued at US$ 43650 million in 2023. With growing demand in downstream market, the Antivirals is forecast to a readjusted size of US$ 60070 million by 2030 with a CAGR of 4.7% during review period.
The research report highlights the growth potential of the global Antivirals market. Antivirals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Antivirals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Antivirals market.
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Antivirals market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Antivirals market. It may include historical data, market segmentation by Type (e.g., Generic, Branded), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Antivirals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Antivirals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Antivirals industry. This include advancements in Antivirals technology, Antivirals new entrants, Antivirals new investment, and other innovations that are shaping the future of Antivirals.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Antivirals market. It includes factors influencing customer ' purchasing decisions, preferences for Antivirals product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Antivirals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Antivirals market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Antivirals market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Antivirals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Antivirals market.
Market Segmentation:
Antivirals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Generic
- Branded
- HIV
- Hepatitis
- HSV
- Influenza
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Johnson & Johnson
- Teva Pharmaceutical Industries
- GSK
- Mylan
- Gilead Sciences
- F. Hoffmann-La Roche
- Bristol-Myers-Squibb
- AbbVie
- Aurobindo Pharma
- Cipla
- Dr Reddy’s
What is the 10-year outlook for the global Antivirals market?
What factors are driving Antivirals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antivirals market opportunities vary by end market size?
How does Antivirals break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antivirals Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Antivirals by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Antivirals by Country/Region, 2019, 2023 & 2030
2.2 Antivirals Segment by Type
2.2.1 Generic
2.2.2 Branded
2.3 Antivirals Sales by Type
2.3.1 Global Antivirals Sales Market Share by Type (2019-2024)
2.3.2 Global Antivirals Revenue and Market Share by Type (2019-2024)
2.3.3 Global Antivirals Sale Price by Type (2019-2024)
2.4 Antivirals Segment by Application
2.4.1 HIV
2.4.2 Hepatitis
2.4.3 HSV
2.4.4 Influenza
2.5 Antivirals Sales by Application
2.5.1 Global Antivirals Sale Market Share by Application (2019-2024)
2.5.2 Global Antivirals Revenue and Market Share by Application (2019-2024)
2.5.3 Global Antivirals Sale Price by Application (2019-2024)
3 GLOBAL ANTIVIRALS BY COMPANY
3.1 Global Antivirals Breakdown Data by Company
3.1.1 Global Antivirals Annual Sales by Company (2019-2024)
3.1.2 Global Antivirals Sales Market Share by Company (2019-2024)
3.2 Global Antivirals Annual Revenue by Company (2019-2024)
3.2.1 Global Antivirals Revenue by Company (2019-2024)
3.2.2 Global Antivirals Revenue Market Share by Company (2019-2024)
3.3 Global Antivirals Sale Price by Company
3.4 Key Manufacturers Antivirals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antivirals Product Location Distribution
3.4.2 Players Antivirals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTIVIRALS BY GEOGRAPHIC REGION
4.1 World Historic Antivirals Market Size by Geographic Region (2019-2024)
4.1.1 Global Antivirals Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Antivirals Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Antivirals Market Size by Country/Region (2019-2024)
4.2.1 Global Antivirals Annual Sales by Country/Region (2019-2024)
4.2.2 Global Antivirals Annual Revenue by Country/Region (2019-2024)
4.3 Americas Antivirals Sales Growth
4.4 APAC Antivirals Sales Growth
4.5 Europe Antivirals Sales Growth
4.6 Middle East & Africa Antivirals Sales Growth
5 AMERICAS
5.1 Americas Antivirals Sales by Country
5.1.1 Americas Antivirals Sales by Country (2019-2024)
5.1.2 Americas Antivirals Revenue by Country (2019-2024)
5.2 Americas Antivirals Sales by Type
5.3 Americas Antivirals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antivirals Sales by Region
6.1.1 APAC Antivirals Sales by Region (2019-2024)
6.1.2 APAC Antivirals Revenue by Region (2019-2024)
6.2 APAC Antivirals Sales by Type
6.3 APAC Antivirals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antivirals by Country
7.1.1 Europe Antivirals Sales by Country (2019-2024)
7.1.2 Europe Antivirals Revenue by Country (2019-2024)
7.2 Europe Antivirals Sales by Type
7.3 Europe Antivirals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antivirals by Country
8.1.1 Middle East & Africa Antivirals Sales by Country (2019-2024)
8.1.2 Middle East & Africa Antivirals Revenue by Country (2019-2024)
8.2 Middle East & Africa Antivirals Sales by Type
8.3 Middle East & Africa Antivirals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antivirals
10.3 Manufacturing Process Analysis of Antivirals
10.4 Industry Chain Structure of Antivirals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antivirals Distributors
11.3 Antivirals Customer
12 WORLD FORECAST REVIEW FOR ANTIVIRALS BY GEOGRAPHIC REGION
12.1 Global Antivirals Market Size Forecast by Region
12.1.1 Global Antivirals Forecast by Region (2025-2030)
12.1.2 Global Antivirals Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antivirals Forecast by Type
12.7 Global Antivirals Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Antivirals Product Portfolios and Specifications
13.1.3 Merck Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Antivirals Product Portfolios and Specifications
13.2.3 Johnson & Johnson Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Information
13.3.2 Teva Pharmaceutical Industries Antivirals Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Teva Pharmaceutical Industries Main Business Overview
13.3.5 Teva Pharmaceutical Industries Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Antivirals Product Portfolios and Specifications
13.4.3 GSK Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Antivirals Product Portfolios and Specifications
13.5.3 Mylan Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Gilead Sciences
13.6.1 Gilead Sciences Company Information
13.6.2 Gilead Sciences Antivirals Product Portfolios and Specifications
13.6.3 Gilead Sciences Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Gilead Sciences Main Business Overview
13.6.5 Gilead Sciences Latest Developments
13.7 F. Hoffmann-La Roche
13.7.1 F. Hoffmann-La Roche Company Information
13.7.2 F. Hoffmann-La Roche Antivirals Product Portfolios and Specifications
13.7.3 F. Hoffmann-La Roche Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 F. Hoffmann-La Roche Main Business Overview
13.7.5 F. Hoffmann-La Roche Latest Developments
13.8 Bristol-Myers-Squibb
13.8.1 Bristol-Myers-Squibb Company Information
13.8.2 Bristol-Myers-Squibb Antivirals Product Portfolios and Specifications
13.8.3 Bristol-Myers-Squibb Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Bristol-Myers-Squibb Main Business Overview
13.8.5 Bristol-Myers-Squibb Latest Developments
13.9 AbbVie
13.9.1 AbbVie Company Information
13.9.2 AbbVie Antivirals Product Portfolios and Specifications
13.9.3 AbbVie Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 AbbVie Main Business Overview
13.9.5 AbbVie Latest Developments
13.10 Aurobindo Pharma
13.10.1 Aurobindo Pharma Company Information
13.10.2 Aurobindo Pharma Antivirals Product Portfolios and Specifications
13.10.3 Aurobindo Pharma Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Aurobindo Pharma Main Business Overview
13.10.5 Aurobindo Pharma Latest Developments
13.11 Cipla
13.11.1 Cipla Company Information
13.11.2 Cipla Antivirals Product Portfolios and Specifications
13.11.3 Cipla Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Cipla Main Business Overview
13.11.5 Cipla Latest Developments
13.12 Dr Reddy’s
13.12.1 Dr Reddy’s Company Information
13.12.2 Dr Reddy’s Antivirals Product Portfolios and Specifications
13.12.3 Dr Reddy’s Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Dr Reddy’s Main Business Overview
13.12.5 Dr Reddy’s Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antivirals Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Antivirals by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Antivirals by Country/Region, 2019, 2023 & 2030
2.2 Antivirals Segment by Type
2.2.1 Generic
2.2.2 Branded
2.3 Antivirals Sales by Type
2.3.1 Global Antivirals Sales Market Share by Type (2019-2024)
2.3.2 Global Antivirals Revenue and Market Share by Type (2019-2024)
2.3.3 Global Antivirals Sale Price by Type (2019-2024)
2.4 Antivirals Segment by Application
2.4.1 HIV
2.4.2 Hepatitis
2.4.3 HSV
2.4.4 Influenza
2.5 Antivirals Sales by Application
2.5.1 Global Antivirals Sale Market Share by Application (2019-2024)
2.5.2 Global Antivirals Revenue and Market Share by Application (2019-2024)
2.5.3 Global Antivirals Sale Price by Application (2019-2024)
3 GLOBAL ANTIVIRALS BY COMPANY
3.1 Global Antivirals Breakdown Data by Company
3.1.1 Global Antivirals Annual Sales by Company (2019-2024)
3.1.2 Global Antivirals Sales Market Share by Company (2019-2024)
3.2 Global Antivirals Annual Revenue by Company (2019-2024)
3.2.1 Global Antivirals Revenue by Company (2019-2024)
3.2.2 Global Antivirals Revenue Market Share by Company (2019-2024)
3.3 Global Antivirals Sale Price by Company
3.4 Key Manufacturers Antivirals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antivirals Product Location Distribution
3.4.2 Players Antivirals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTIVIRALS BY GEOGRAPHIC REGION
4.1 World Historic Antivirals Market Size by Geographic Region (2019-2024)
4.1.1 Global Antivirals Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Antivirals Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Antivirals Market Size by Country/Region (2019-2024)
4.2.1 Global Antivirals Annual Sales by Country/Region (2019-2024)
4.2.2 Global Antivirals Annual Revenue by Country/Region (2019-2024)
4.3 Americas Antivirals Sales Growth
4.4 APAC Antivirals Sales Growth
4.5 Europe Antivirals Sales Growth
4.6 Middle East & Africa Antivirals Sales Growth
5 AMERICAS
5.1 Americas Antivirals Sales by Country
5.1.1 Americas Antivirals Sales by Country (2019-2024)
5.1.2 Americas Antivirals Revenue by Country (2019-2024)
5.2 Americas Antivirals Sales by Type
5.3 Americas Antivirals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antivirals Sales by Region
6.1.1 APAC Antivirals Sales by Region (2019-2024)
6.1.2 APAC Antivirals Revenue by Region (2019-2024)
6.2 APAC Antivirals Sales by Type
6.3 APAC Antivirals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antivirals by Country
7.1.1 Europe Antivirals Sales by Country (2019-2024)
7.1.2 Europe Antivirals Revenue by Country (2019-2024)
7.2 Europe Antivirals Sales by Type
7.3 Europe Antivirals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antivirals by Country
8.1.1 Middle East & Africa Antivirals Sales by Country (2019-2024)
8.1.2 Middle East & Africa Antivirals Revenue by Country (2019-2024)
8.2 Middle East & Africa Antivirals Sales by Type
8.3 Middle East & Africa Antivirals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antivirals
10.3 Manufacturing Process Analysis of Antivirals
10.4 Industry Chain Structure of Antivirals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antivirals Distributors
11.3 Antivirals Customer
12 WORLD FORECAST REVIEW FOR ANTIVIRALS BY GEOGRAPHIC REGION
12.1 Global Antivirals Market Size Forecast by Region
12.1.1 Global Antivirals Forecast by Region (2025-2030)
12.1.2 Global Antivirals Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antivirals Forecast by Type
12.7 Global Antivirals Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Antivirals Product Portfolios and Specifications
13.1.3 Merck Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Antivirals Product Portfolios and Specifications
13.2.3 Johnson & Johnson Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Information
13.3.2 Teva Pharmaceutical Industries Antivirals Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Teva Pharmaceutical Industries Main Business Overview
13.3.5 Teva Pharmaceutical Industries Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Antivirals Product Portfolios and Specifications
13.4.3 GSK Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Antivirals Product Portfolios and Specifications
13.5.3 Mylan Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Gilead Sciences
13.6.1 Gilead Sciences Company Information
13.6.2 Gilead Sciences Antivirals Product Portfolios and Specifications
13.6.3 Gilead Sciences Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Gilead Sciences Main Business Overview
13.6.5 Gilead Sciences Latest Developments
13.7 F. Hoffmann-La Roche
13.7.1 F. Hoffmann-La Roche Company Information
13.7.2 F. Hoffmann-La Roche Antivirals Product Portfolios and Specifications
13.7.3 F. Hoffmann-La Roche Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 F. Hoffmann-La Roche Main Business Overview
13.7.5 F. Hoffmann-La Roche Latest Developments
13.8 Bristol-Myers-Squibb
13.8.1 Bristol-Myers-Squibb Company Information
13.8.2 Bristol-Myers-Squibb Antivirals Product Portfolios and Specifications
13.8.3 Bristol-Myers-Squibb Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Bristol-Myers-Squibb Main Business Overview
13.8.5 Bristol-Myers-Squibb Latest Developments
13.9 AbbVie
13.9.1 AbbVie Company Information
13.9.2 AbbVie Antivirals Product Portfolios and Specifications
13.9.3 AbbVie Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 AbbVie Main Business Overview
13.9.5 AbbVie Latest Developments
13.10 Aurobindo Pharma
13.10.1 Aurobindo Pharma Company Information
13.10.2 Aurobindo Pharma Antivirals Product Portfolios and Specifications
13.10.3 Aurobindo Pharma Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Aurobindo Pharma Main Business Overview
13.10.5 Aurobindo Pharma Latest Developments
13.11 Cipla
13.11.1 Cipla Company Information
13.11.2 Cipla Antivirals Product Portfolios and Specifications
13.11.3 Cipla Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Cipla Main Business Overview
13.11.5 Cipla Latest Developments
13.12 Dr Reddy’s
13.12.1 Dr Reddy’s Company Information
13.12.2 Dr Reddy’s Antivirals Product Portfolios and Specifications
13.12.3 Dr Reddy’s Antivirals Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Dr Reddy’s Main Business Overview
13.12.5 Dr Reddy’s Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Antivirals Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Antivirals Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Generic
Table 4. Major Players of Branded
Table 5. Global Antivirals Sales by Type (2019-2024) & (K MT)
Table 6. Global Antivirals Sales Market Share by Type (2019-2024)
Table 7. Global Antivirals Revenue by Type (2019-2024) & ($ million)
Table 8. Global Antivirals Revenue Market Share by Type (2019-2024)
Table 9. Global Antivirals Sale Price by Type (2019-2024) & (USD/MT)
Table 10. Global Antivirals Sales by Application (2019-2024) & (K MT)
Table 11. Global Antivirals Sales Market Share by Application (2019-2024)
Table 12. Global Antivirals Revenue by Application (2019-2024)
Table 13. Global Antivirals Revenue Market Share by Application (2019-2024)
Table 14. Global Antivirals Sale Price by Application (2019-2024) & (USD/MT)
Table 15. Global Antivirals Sales by Company (2019-2024) & (K MT)
Table 16. Global Antivirals Sales Market Share by Company (2019-2024)
Table 17. Global Antivirals Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Antivirals Revenue Market Share by Company (2019-2024)
Table 19. Global Antivirals Sale Price by Company (2019-2024) & (USD/MT)
Table 20. Key Manufacturers Antivirals Producing Area Distribution and Sales Area
Table 21. Players Antivirals Products Offered
Table 22. Antivirals Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Antivirals Sales by Geographic Region (2019-2024) & (K MT)
Table 26. Global Antivirals Sales Market Share Geographic Region (2019-2024)
Table 27. Global Antivirals Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Antivirals Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Antivirals Sales by Country/Region (2019-2024) & (K MT)
Table 30. Global Antivirals Sales Market Share by Country/Region (2019-2024)
Table 31. Global Antivirals Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Antivirals Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Antivirals Sales by Country (2019-2024) & (K MT)
Table 34. Americas Antivirals Sales Market Share by Country (2019-2024)
Table 35. Americas Antivirals Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Antivirals Revenue Market Share by Country (2019-2024)
Table 37. Americas Antivirals Sales by Type (2019-2024) & (K MT)
Table 38. Americas Antivirals Sales by Application (2019-2024) & (K MT)
Table 39. APAC Antivirals Sales by Region (2019-2024) & (K MT)
Table 40. APAC Antivirals Sales Market Share by Region (2019-2024)
Table 41. APAC Antivirals Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Antivirals Revenue Market Share by Region (2019-2024)
Table 43. APAC Antivirals Sales by Type (2019-2024) & (K MT)
Table 44. APAC Antivirals Sales by Application (2019-2024) & (K MT)
Table 45. Europe Antivirals Sales by Country (2019-2024) & (K MT)
Table 46. Europe Antivirals Sales Market Share by Country (2019-2024)
Table 47. Europe Antivirals Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Antivirals Revenue Market Share by Country (2019-2024)
Table 49. Europe Antivirals Sales by Type (2019-2024) & (K MT)
Table 50. Europe Antivirals Sales by Application (2019-2024) & (K MT)
Table 51. Middle East & Africa Antivirals Sales by Country (2019-2024) & (K MT)
Table 52. Middle East & Africa Antivirals Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Antivirals Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Antivirals Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Antivirals Sales by Type (2019-2024) & (K MT)
Table 56. Middle East & Africa Antivirals Sales by Application (2019-2024) & (K MT)
Table 57. Key Market Drivers & Growth Opportunities of Antivirals
Table 58. Key Market Challenges & Risks of Antivirals
Table 59. Key Industry Trends of Antivirals
Table 60. Antivirals Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Antivirals Distributors List
Table 63. Antivirals Customer List
Table 64. Global Antivirals Sales Forecast by Region (2025-2030) & (K MT)
Table 65. Global Antivirals Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Antivirals Sales Forecast by Country (2025-2030) & (K MT)
Table 67. Americas Antivirals Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Antivirals Sales Forecast by Region (2025-2030) & (K MT)
Table 69. APAC Antivirals Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Antivirals Sales Forecast by Country (2025-2030) & (K MT)
Table 71. Europe Antivirals Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Antivirals Sales Forecast by Country (2025-2030) & (K MT)
Table 73. Middle East & Africa Antivirals Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Antivirals Sales Forecast by Type (2025-2030) & (K MT)
Table 75. Global Antivirals Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Antivirals Sales Forecast by Application (2025-2030) & (K MT)
Table 77. Global Antivirals Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Merck Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Antivirals Product Portfolios and Specifications
Table 80. Merck Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Johnson & Johnson Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 84. Johnson & Johnson Antivirals Product Portfolios and Specifications
Table 85. Johnson & Johnson Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Teva Pharmaceutical Industries Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Pharmaceutical Industries Antivirals Product Portfolios and Specifications
Table 90. Teva Pharmaceutical Industries Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 91. Teva Pharmaceutical Industries Main Business
Table 92. Teva Pharmaceutical Industries Latest Developments
Table 93. GSK Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK Antivirals Product Portfolios and Specifications
Table 95. GSK Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. Mylan Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan Antivirals Product Portfolios and Specifications
Table 100. Mylan Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 101. Mylan Main Business
Table 102. Mylan Latest Developments
Table 103. Gilead Sciences Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 104. Gilead Sciences Antivirals Product Portfolios and Specifications
Table 105. Gilead Sciences Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 106. Gilead Sciences Main Business
Table 107. Gilead Sciences Latest Developments
Table 108. F. Hoffmann-La Roche Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 109. F. Hoffmann-La Roche Antivirals Product Portfolios and Specifications
Table 110. F. Hoffmann-La Roche Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 111. F. Hoffmann-La Roche Main Business
Table 112. F. Hoffmann-La Roche Latest Developments
Table 113. Bristol-Myers-Squibb Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 114. Bristol-Myers-Squibb Antivirals Product Portfolios and Specifications
Table 115. Bristol-Myers-Squibb Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 116. Bristol-Myers-Squibb Main Business
Table 117. Bristol-Myers-Squibb Latest Developments
Table 118. AbbVie Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 119. AbbVie Antivirals Product Portfolios and Specifications
Table 120. AbbVie Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 121. AbbVie Main Business
Table 122. AbbVie Latest Developments
Table 123. Aurobindo Pharma Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 124. Aurobindo Pharma Antivirals Product Portfolios and Specifications
Table 125. Aurobindo Pharma Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 126. Aurobindo Pharma Main Business
Table 127. Aurobindo Pharma Latest Developments
Table 128. Cipla Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 129. Cipla Antivirals Product Portfolios and Specifications
Table 130. Cipla Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 131. Cipla Main Business
Table 132. Cipla Latest Developments
Table 133. Dr Reddy’s Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 134. Dr Reddy’s Antivirals Product Portfolios and Specifications
Table 135. Dr Reddy’s Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 136. Dr Reddy’s Main Business
Table 137. Dr Reddy’s Latest Developments
.
Table 1. Antivirals Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Antivirals Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Generic
Table 4. Major Players of Branded
Table 5. Global Antivirals Sales by Type (2019-2024) & (K MT)
Table 6. Global Antivirals Sales Market Share by Type (2019-2024)
Table 7. Global Antivirals Revenue by Type (2019-2024) & ($ million)
Table 8. Global Antivirals Revenue Market Share by Type (2019-2024)
Table 9. Global Antivirals Sale Price by Type (2019-2024) & (USD/MT)
Table 10. Global Antivirals Sales by Application (2019-2024) & (K MT)
Table 11. Global Antivirals Sales Market Share by Application (2019-2024)
Table 12. Global Antivirals Revenue by Application (2019-2024)
Table 13. Global Antivirals Revenue Market Share by Application (2019-2024)
Table 14. Global Antivirals Sale Price by Application (2019-2024) & (USD/MT)
Table 15. Global Antivirals Sales by Company (2019-2024) & (K MT)
Table 16. Global Antivirals Sales Market Share by Company (2019-2024)
Table 17. Global Antivirals Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Antivirals Revenue Market Share by Company (2019-2024)
Table 19. Global Antivirals Sale Price by Company (2019-2024) & (USD/MT)
Table 20. Key Manufacturers Antivirals Producing Area Distribution and Sales Area
Table 21. Players Antivirals Products Offered
Table 22. Antivirals Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Antivirals Sales by Geographic Region (2019-2024) & (K MT)
Table 26. Global Antivirals Sales Market Share Geographic Region (2019-2024)
Table 27. Global Antivirals Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Antivirals Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Antivirals Sales by Country/Region (2019-2024) & (K MT)
Table 30. Global Antivirals Sales Market Share by Country/Region (2019-2024)
Table 31. Global Antivirals Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Antivirals Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Antivirals Sales by Country (2019-2024) & (K MT)
Table 34. Americas Antivirals Sales Market Share by Country (2019-2024)
Table 35. Americas Antivirals Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Antivirals Revenue Market Share by Country (2019-2024)
Table 37. Americas Antivirals Sales by Type (2019-2024) & (K MT)
Table 38. Americas Antivirals Sales by Application (2019-2024) & (K MT)
Table 39. APAC Antivirals Sales by Region (2019-2024) & (K MT)
Table 40. APAC Antivirals Sales Market Share by Region (2019-2024)
Table 41. APAC Antivirals Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Antivirals Revenue Market Share by Region (2019-2024)
Table 43. APAC Antivirals Sales by Type (2019-2024) & (K MT)
Table 44. APAC Antivirals Sales by Application (2019-2024) & (K MT)
Table 45. Europe Antivirals Sales by Country (2019-2024) & (K MT)
Table 46. Europe Antivirals Sales Market Share by Country (2019-2024)
Table 47. Europe Antivirals Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Antivirals Revenue Market Share by Country (2019-2024)
Table 49. Europe Antivirals Sales by Type (2019-2024) & (K MT)
Table 50. Europe Antivirals Sales by Application (2019-2024) & (K MT)
Table 51. Middle East & Africa Antivirals Sales by Country (2019-2024) & (K MT)
Table 52. Middle East & Africa Antivirals Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Antivirals Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Antivirals Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Antivirals Sales by Type (2019-2024) & (K MT)
Table 56. Middle East & Africa Antivirals Sales by Application (2019-2024) & (K MT)
Table 57. Key Market Drivers & Growth Opportunities of Antivirals
Table 58. Key Market Challenges & Risks of Antivirals
Table 59. Key Industry Trends of Antivirals
Table 60. Antivirals Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Antivirals Distributors List
Table 63. Antivirals Customer List
Table 64. Global Antivirals Sales Forecast by Region (2025-2030) & (K MT)
Table 65. Global Antivirals Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Antivirals Sales Forecast by Country (2025-2030) & (K MT)
Table 67. Americas Antivirals Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Antivirals Sales Forecast by Region (2025-2030) & (K MT)
Table 69. APAC Antivirals Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Antivirals Sales Forecast by Country (2025-2030) & (K MT)
Table 71. Europe Antivirals Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Antivirals Sales Forecast by Country (2025-2030) & (K MT)
Table 73. Middle East & Africa Antivirals Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Antivirals Sales Forecast by Type (2025-2030) & (K MT)
Table 75. Global Antivirals Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Antivirals Sales Forecast by Application (2025-2030) & (K MT)
Table 77. Global Antivirals Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Merck Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Antivirals Product Portfolios and Specifications
Table 80. Merck Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Johnson & Johnson Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 84. Johnson & Johnson Antivirals Product Portfolios and Specifications
Table 85. Johnson & Johnson Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Teva Pharmaceutical Industries Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Pharmaceutical Industries Antivirals Product Portfolios and Specifications
Table 90. Teva Pharmaceutical Industries Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 91. Teva Pharmaceutical Industries Main Business
Table 92. Teva Pharmaceutical Industries Latest Developments
Table 93. GSK Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK Antivirals Product Portfolios and Specifications
Table 95. GSK Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. Mylan Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan Antivirals Product Portfolios and Specifications
Table 100. Mylan Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 101. Mylan Main Business
Table 102. Mylan Latest Developments
Table 103. Gilead Sciences Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 104. Gilead Sciences Antivirals Product Portfolios and Specifications
Table 105. Gilead Sciences Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 106. Gilead Sciences Main Business
Table 107. Gilead Sciences Latest Developments
Table 108. F. Hoffmann-La Roche Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 109. F. Hoffmann-La Roche Antivirals Product Portfolios and Specifications
Table 110. F. Hoffmann-La Roche Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 111. F. Hoffmann-La Roche Main Business
Table 112. F. Hoffmann-La Roche Latest Developments
Table 113. Bristol-Myers-Squibb Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 114. Bristol-Myers-Squibb Antivirals Product Portfolios and Specifications
Table 115. Bristol-Myers-Squibb Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 116. Bristol-Myers-Squibb Main Business
Table 117. Bristol-Myers-Squibb Latest Developments
Table 118. AbbVie Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 119. AbbVie Antivirals Product Portfolios and Specifications
Table 120. AbbVie Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 121. AbbVie Main Business
Table 122. AbbVie Latest Developments
Table 123. Aurobindo Pharma Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 124. Aurobindo Pharma Antivirals Product Portfolios and Specifications
Table 125. Aurobindo Pharma Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 126. Aurobindo Pharma Main Business
Table 127. Aurobindo Pharma Latest Developments
Table 128. Cipla Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 129. Cipla Antivirals Product Portfolios and Specifications
Table 130. Cipla Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 131. Cipla Main Business
Table 132. Cipla Latest Developments
Table 133. Dr Reddy’s Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors
Table 134. Dr Reddy’s Antivirals Product Portfolios and Specifications
Table 135. Dr Reddy’s Antivirals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 136. Dr Reddy’s Main Business
Table 137. Dr Reddy’s Latest Developments
LIST OF FIGURES
.
Figure 1. Picture of Antivirals
Figure 2. Antivirals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antivirals Sales Growth Rate 2019-2030 (K MT)
Figure 7. Global Antivirals Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Antivirals Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Generic
Figure 10. Product Picture of Branded
Figure 11. Global Antivirals Sales Market Share by Type in 2023
Figure 12. Global Antivirals Revenue Market Share by Type (2019-2024)
Figure 13. Antivirals Consumed in HIV
Figure 14. Global Antivirals Market: HIV (2019-2024) & (K MT)
Figure 15. Antivirals Consumed in Hepatitis
Figure 16. Global Antivirals Market: Hepatitis (2019-2024) & (K MT)
Figure 17. Antivirals Consumed in HSV
Figure 18. Global Antivirals Market: HSV (2019-2024) & (K MT)
Figure 19. Antivirals Consumed in Influenza
Figure 20. Global Antivirals Market: Influenza (2019-2024) & (K MT)
Figure 21. Global Antivirals Sales Market Share by Application (2023)
Figure 22. Global Antivirals Revenue Market Share by Application in 2023
Figure 23. Antivirals Sales Market by Company in 2023 (K MT)
Figure 24. Global Antivirals Sales Market Share by Company in 2023
Figure 25. Antivirals Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Antivirals Revenue Market Share by Company in 2023
Figure 27. Global Antivirals Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Antivirals Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Antivirals Sales 2019-2024 (K MT)
Figure 30. Americas Antivirals Revenue 2019-2024 ($ Millions)
Figure 31. APAC Antivirals Sales 2019-2024 (K MT)
Figure 32. APAC Antivirals Revenue 2019-2024 ($ Millions)
Figure 33. Europe Antivirals Sales 2019-2024 (K MT)
Figure 34. Europe Antivirals Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Antivirals Sales 2019-2024 (K MT)
Figure 36. Middle East & Africa Antivirals Revenue 2019-2024 ($ Millions)
Figure 37. Americas Antivirals Sales Market Share by Country in 2023
Figure 38. Americas Antivirals Revenue Market Share by Country in 2023
Figure 39. Americas Antivirals Sales Market Share by Type (2019-2024)
Figure 40. Americas Antivirals Sales Market Share by Application (2019-2024)
Figure 41. United States Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Antivirals Sales Market Share by Region in 2023
Figure 46. APAC Antivirals Revenue Market Share by Regions in 2023
Figure 47. APAC Antivirals Sales Market Share by Type (2019-2024)
Figure 48. APAC Antivirals Sales Market Share by Application (2019-2024)
Figure 49. China Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Antivirals Sales Market Share by Country in 2023
Figure 57. Europe Antivirals Revenue Market Share by Country in 2023
Figure 58. Europe Antivirals Sales Market Share by Type (2019-2024)
Figure 59. Europe Antivirals Sales Market Share by Application (2019-2024)
Figure 60. Germany Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Antivirals Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Antivirals Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Antivirals Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Antivirals Sales Market Share by Application (2019-2024)
Figure 69. Egypt Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Antivirals in 2023
Figure 75. Manufacturing Process Analysis of Antivirals
Figure 76. Industry Chain Structure of Antivirals
Figure 77. Channels of Distribution
Figure 78. Global Antivirals Sales Market Forecast by Region (2025-2030)
Figure 79. Global Antivirals Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Antivirals Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Antivirals Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Antivirals Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Antivirals Revenue Market Share Forecast by Application (2025-2030)
.
Figure 1. Picture of Antivirals
Figure 2. Antivirals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antivirals Sales Growth Rate 2019-2030 (K MT)
Figure 7. Global Antivirals Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Antivirals Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Generic
Figure 10. Product Picture of Branded
Figure 11. Global Antivirals Sales Market Share by Type in 2023
Figure 12. Global Antivirals Revenue Market Share by Type (2019-2024)
Figure 13. Antivirals Consumed in HIV
Figure 14. Global Antivirals Market: HIV (2019-2024) & (K MT)
Figure 15. Antivirals Consumed in Hepatitis
Figure 16. Global Antivirals Market: Hepatitis (2019-2024) & (K MT)
Figure 17. Antivirals Consumed in HSV
Figure 18. Global Antivirals Market: HSV (2019-2024) & (K MT)
Figure 19. Antivirals Consumed in Influenza
Figure 20. Global Antivirals Market: Influenza (2019-2024) & (K MT)
Figure 21. Global Antivirals Sales Market Share by Application (2023)
Figure 22. Global Antivirals Revenue Market Share by Application in 2023
Figure 23. Antivirals Sales Market by Company in 2023 (K MT)
Figure 24. Global Antivirals Sales Market Share by Company in 2023
Figure 25. Antivirals Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Antivirals Revenue Market Share by Company in 2023
Figure 27. Global Antivirals Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Antivirals Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Antivirals Sales 2019-2024 (K MT)
Figure 30. Americas Antivirals Revenue 2019-2024 ($ Millions)
Figure 31. APAC Antivirals Sales 2019-2024 (K MT)
Figure 32. APAC Antivirals Revenue 2019-2024 ($ Millions)
Figure 33. Europe Antivirals Sales 2019-2024 (K MT)
Figure 34. Europe Antivirals Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Antivirals Sales 2019-2024 (K MT)
Figure 36. Middle East & Africa Antivirals Revenue 2019-2024 ($ Millions)
Figure 37. Americas Antivirals Sales Market Share by Country in 2023
Figure 38. Americas Antivirals Revenue Market Share by Country in 2023
Figure 39. Americas Antivirals Sales Market Share by Type (2019-2024)
Figure 40. Americas Antivirals Sales Market Share by Application (2019-2024)
Figure 41. United States Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Antivirals Sales Market Share by Region in 2023
Figure 46. APAC Antivirals Revenue Market Share by Regions in 2023
Figure 47. APAC Antivirals Sales Market Share by Type (2019-2024)
Figure 48. APAC Antivirals Sales Market Share by Application (2019-2024)
Figure 49. China Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Antivirals Sales Market Share by Country in 2023
Figure 57. Europe Antivirals Revenue Market Share by Country in 2023
Figure 58. Europe Antivirals Sales Market Share by Type (2019-2024)
Figure 59. Europe Antivirals Sales Market Share by Application (2019-2024)
Figure 60. Germany Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Antivirals Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Antivirals Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Antivirals Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Antivirals Sales Market Share by Application (2019-2024)
Figure 69. Egypt Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Antivirals Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Antivirals in 2023
Figure 75. Manufacturing Process Analysis of Antivirals
Figure 76. Industry Chain Structure of Antivirals
Figure 77. Channels of Distribution
Figure 78. Global Antivirals Sales Market Forecast by Region (2025-2030)
Figure 79. Global Antivirals Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Antivirals Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Antivirals Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Antivirals Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Antivirals Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Glass Bottles and Vials for Vaccines & Pharmaceuticals Market Growth 2023-2029
US$ 3,660.00
March 2023
101 pages
Global Ginseng Powder Market Growth 2025-2031
US$ 3,660.00
October 2025
124 pages
Global Estrogen Replacement Therapy Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
101 pages
Global Kids Desk Lamp Market Growth 2026-2032
US$ 3,660.00
May 2026
184 pages
Global Amniotic Hooks Market Growth 2024-2030
US$ 3,660.00
September 2024
98 pages
